Published Date: 29 Jul 2025
Prostate cancer is one of the most common cancers in the world. While many prostate cancers grow slowly and remain localized, other types are aggressive and spread quickly. That's why Dr. Carlos Vargas, a Mayo Clinic radiation ...
Read Full News1.
Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma
2.
For older patients with Hodgkin lymphoma, novel regimens produce high response rates.
3.
Prostate cancer explained: From antigen tests to treatment options
4.
The importance of breast cancer screening
5.
Dual Targeted CAR-T Yields 99% Response Rate in Pediatric ALL
1.
The Essential Roadmap for Nutritional Excellence in Head and Neck Cancer Care
2.
The Mystery of Carotid Body Tumors: The Facts You Need to Know
3.
Oncology Trials Roadmap: From Drug Discovery to Delivery and Patient Access
4.
Myeloproliferative Disorders: Causes, Symptoms and Treatment Options
5.
Cutting-Edge Cancer Treatments: Innovations and Outcomes in Non-Hodgkin Lymphoma
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Navigating the Complexities of Ph Negative ALL - Part XV
2.
Breaking Down PALOMA-2: How CDK4/6 Inhibitors Redefined Treatment for HR+/HER2- Metastatic Breast Cancer
3.
Recent Data Analysis for First-Line Treatment of ALK+ NSCLC: A Continuation
4.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
5.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation